Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticlePERSPECTIVES IN PHARMACOLOGY

Altered Uric Acid Levels and Disease States

Melinda K. Kutzing and Bonnie L. Firestein
Journal of Pharmacology and Experimental Therapeutics January 2008, 324 (1) 1-7; DOI: https://doi.org/10.1124/jpet.107.129031
Melinda K. Kutzing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bonnie L. Firestein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 324 no. 1 1-7
DOI 
https://doi.org/10.1124/jpet.107.129031
PubMed 
17890445

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received July 23, 2007
  • Accepted September 20, 2007
  • Published online December 19, 2007.

Article Versions

  • Earlier version (September 21, 2007 - 11:01).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Melinda K. Kutzing and
  2. Bonnie L. Firestein
  1. Department of Cell Biology and Neuroscience (M.K.K., B.L.F.), Graduate Program in Biomedical Engineering (M.K.K.), Rutgers University, Piscataway, New Jersey
  1. Address correspondence to:
    Dr. Bonnie L. Firestein, Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854-8082. E-mail: firestein{at}biology.rutgers.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2007 to May 2022

AbstractFullPdf
Sep 2007450103
Oct 2007350177
Nov 2007130126
Dec 200711824121
Jan 200818082159
Feb 200882116115
Mar 20088860105
Apr 2008713995
May 2008643581
Jun 2008643380
Jul 2008533152
Aug 2008653466
Sep 2008402851
Oct 2008702860
Nov 2008612347
Dec 20084018164
Jan 20093171252
Feb 20094281240
Mar 20093677214
Apr 20093671117
May 2009165471
Jun 2009356585
Jul 2009526369
Aug 2009446971
Sep 2009285769
Oct 2009345877
Nov 2009272962
Dec 2009512638
Jan 2010515556
Feb 2010554452
Mar 2010627070
Apr 2010265141
May 2010237149
Jun 2010197353
Jul 2010407556
Aug 2010628650
Sep 2010426549
Oct 2010439656
Nov 2010357236
Dec 2010379858
Jan 2011486550
Feb 2011595234
Mar 20115810374
Apr 2011299048
May 2011348640
Jun 2011358835
Jul 2011387354
Aug 2011316964
Sep 20113813361
Oct 2011378448
Nov 20114113885
Dec 20114246665
Jan 20128111957
Feb 20126022560
Mar 20125720782
Apr 20124519872
May 20124420370
Jun 20125622667
Jul 20124817571
Aug 20127323962
Sep 20125229081
Oct 20126350490
Nov 20126361090
Dec 20125663285
Jan 20138769293
Feb 20135269062
Mar 20137060780
Apr 201387617102
May 20136446995
Jun 20135047272
Jul 20133958871
Aug 20135861181
Sep 20136657982
Oct 20138035379
Nov 20135436864
Dec 20135126464
Jan 20146927985
Feb 20144625667
Mar 20144537567
Apr 20144840362
May 201475567105
Jun 20145843188
Jul 201410342660
Aug 20145637744
Sep 20145342468
Oct 20147022743
Nov 2014516841
Dec 20144013533
Jan 20155916641
Feb 20153713239
Mar 20156925172
Apr 20155322957
May 201511747484
Jun 20156155352
Jul 20154638038
Aug 20155039444
Sep 20154740458
Oct 20157945162
Nov 20156535940
Dec 20153530046
Jan 201610535759
Feb 20166230062
Mar 201610138180
Apr 20165934545
May 20165827135
Jun 20165618137
Jul 20166116242
Aug 20164616848
Sep 20163314855
Oct 20164016736
Nov 20164518941
Dec 20162119140
Jan 2017517231
Feb 2017326553
Mar 2017031750
Apr 2017717027
May 20171016339
Jun 2017210024
Jul 201778921
Aug 2017413322
Sep 2017513034
Oct 20171022954
Nov 20171323860
Dec 20171534228
Jan 20181023854
Feb 20181219946
Mar 20181027842
Apr 20181025052
May 2018726124
Jun 20181321228
Jul 2018937340
Aug 2018919027
Sep 20181226838
Oct 2018226625
Nov 2018426427
Dec 2018145497
Jan 2019333135
Feb 2019252105
Mar 2019269209
Apr 201936144
May 20193621014
Jun 201932542
Jul 201920835
Aug 2019191202
Sep 2019195174
Oct 201915553
Nov 201915033
Dec 20199233
Jan 202011483
Feb 20207513
Mar 20206823
Apr 20207983
May 20208613
Jun 20204901
Jul 20206233
Aug 20204303
Sep 20206251
Oct 20205413
Nov 20207444
Dec 20207345
Jan 20219137
Feb 20218968
Mar 20218437
Apr 2021165812
May 20219355
Jun 20216035
Jul 20217349
Aug 20219977
Sep 20217786
Oct 20218945
Nov 202112084
Dec 20219043
Jan 20221001015
Feb 202213171
Mar 202213052
Apr 20221771817
May 20221061510

Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 381 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 381, Issue 2
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Altered Uric Acid Levels and Disease States
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticlePERSPECTIVES IN PHARMACOLOGY

Altered Uric Acid Levels and Disease States

Melinda K. Kutzing and Bonnie L. Firestein
Journal of Pharmacology and Experimental Therapeutics January 1, 2008, 324 (1) 1-7; DOI: https://doi.org/10.1124/jpet.107.129031

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticlePERSPECTIVES IN PHARMACOLOGY

Altered Uric Acid Levels and Disease States

Melinda K. Kutzing and Bonnie L. Firestein
Journal of Pharmacology and Experimental Therapeutics January 1, 2008, 324 (1) 1-7; DOI: https://doi.org/10.1124/jpet.107.129031
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Uric Acid Balance
    • Elevated Uric Acid Levels
    • Hyperuricemia, Gout, and Kidney Disease
    • Hyperuricemia and Hypertension
    • Hyperuricemia and Cardiovascular Disease
    • Elevated Serum Uric Acid Concentration: Cause or Consequence of Disease?
    • Methods for Reducing Serum Uric Acid Levels
    • Reduced Uric Acid Levels
    • The Role of Peroxynitrite in Inflammation
    • Peroxynitrite and Disease
    • Uric Acid and Neuroprotection
    • Reduced Serum Uric Acid Concentration and Disease
    • Reduced Serum Uric Acid Concentration: Cause or Consequence of Disease?
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Acute and Delayed Clinical Manifestations of OP Toxicity
  • Miltefosine as Mediator of the Immune Response
  • Histamine Receptor Knockout Mice
Show more Perspectives in Pharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics